申请人:Kyowa Hakko Kirin Co., Ltd.
公开号:US07605272B2
公开(公告)日:2009-10-20
The present invention provides a type I insulin-like growth factor receptor (IGF-1R) inhibitor comprising, as an active ingredient, an indazole derivative represented by Formula (I):
wherein R1 represents —NR4R5 [wherein R4 represents a hydrogen atom or the like, R5 represents substituted or unsubstituted lower alkyl, —C(═O)R6 (wherein R6 represents substituted or unsubstituted lower alkyl, substituted or unsubstituted aryl or the like), or the like], or the like, and R2 and R3 may be the same or different and each represents a hydrogen atom, hydroxy, substituted or unsubstituted lower alkoxy, or the like} or a pharmaceutically acceptable salt thereof, and the like.
本发明提供了一种I型胰岛素样生长因子受体(IGF-1R)抑制剂,其包括以式(I)表示的吲唑衍生物作为活性成分:其中R1表示—NR4R5 [其中R4表示氢原子或类似物,R5表示取代或未取代的低碳基,—C(═O)R6(其中R6表示取代或未取代的低碳基,取代或未取代的芳基或类似物)或类似物]或类似物,R2和R3可以相同也可以不同,每个表示氢原子,羟基,取代或未取代的低烷氧基或类似物,或类似物。还包括其药学上可接受的盐等。